Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 171 results for "dr reddy"

Buy Dr. Reddy's Laboratories, price target Rs 3,160: Chandan Taparia
Economic Times

Buy Dr. Reddy's Laboratories, price target Rs 3,160: Chandan T...

The analyst suggested a stoploss at Rs 3010 . ETMarkets.com | Updated: Jan 21, 2020, 09.08 AM IST ThinkStock Photos Chandan Taparia of Motilal Oswal Securities has a buy call on Dr. Reddy's Laboratories Ltd. with a target price of Rs 3160.0 . The current ... Economic Times, 5 days ago

78 images for dr reddy

Economic Times, 4 days ago
Economic Times, 5 days ago
Equitymaster.com, 5 days ago
Money Control, 3 weeks ago
Economic Times, 3 weeks ago
Money Control, 3 weeks ago
Economic Times, 1 month ago
Rediff.com, 4 weeks ago
Economic Times, 1 month ago
Economic Times, 1 month ago
Money Control

Drug launch in US bodes well for Dr Reddy’s Labs

 Dr Reddy’s Laboratories on Monday, announced the launch of Sodium Nitroprusside injection, 50 mg/2 ml (25 mg/ml) single-dose vial,in the United State
 Hindu Business Line3 weeks ago Dr Reddy’s launches Sodium Nitroprusside Injection in US  Hindu Business Line3 weeks ago Dr Reddy#39;s launches generic hypotensive injection in US  Money Control3 weeks ago Dr Reddy's launches generic hypotensive injection in US  Economic Times3 weeks ago
[x]  
Economic Times

Buy Dr. Reddy's Labs, price target Rs 2980: Kunal Bothra

The analyst suggested a stop loss at Rs 2855. ETMarkets.com | Updated: Jan 07, 2020, 09.19 AM IST ThinkStock Photos Buy & sell ideas Independent Analyst Kunal Bothra has a buy call on Dr. Reddy's Laboratories Ltd. with a target price of Rs 2980. The current ...
 Economic Times2 weeks ago 'BUY' or 'SELL' ideas from experts for Tuesday, 7 January, 2020  Economic Times2 weeks ago Broker's call: Dr Reddy’s Laboratories  Hindu Business Line1 month ago Nomura has a buy on Dr Reddy’s Labs, target price Rs 3,200  Economic Times1 month ago
[x]  
Money Control

Dr Reddy#39;s gets shareholder#39;s nod for amalgamation of Dr Reddy#39;s Holdings into company

The voting was conducted as per the directions of the Hyderabad Bench of the National Company Law Tribunal on November 22, 2019.
 Money Control3 weeks ago Why Dr Reddy's is set for a rebound  Hindu Business Line1 month ago US-China trade war opens up big opportunity for India pharma sector, says Dr Reddy’s GV Prasad  Hindu Business Line2 months ago Dr Reddy#39;s Chinese gamble -- build biz on early mover advantage, recent tender wins  Money Control2 months ago
Economic Times

Share market update: Nifty Pharma index down; Dr. Reddy's Lab dips 3%

The Nifty Pharma index was trading 0.32 per cent down at 8019.95 . ETMarkets.com | Updated: Dec 13, 2019, 10.20 AM IST Getty Images Among the 50 stocks in the Nifty index, 38 were trading in the green, while 12 were in the red. Company Summary NSE BSE ADD TO ...
 Economic Times1 month ago Market Headstart: Nifty seen opening flat; Dr Reddy’s, Axis Bank top buys  Money Control1 month ago

India vs West Indies Live Score, Over 11 to 15 Latest Cricket Score, Updates

Live Updates of Today Match between India vs West Indies from Dr. Y.S. Rajasekhara Reddy ACA-VDCA Cricket Stadium, Visakhapatnam. Check commentary and full scoreboard of the match.
 NDTV1 month ago West Indies vs India Live Score, Over 1 to 5 Latest Cricket Score, Updates  NDTV1 month ago
Money Control

D-Street Buzz: Auto stocks gain led by Tata Motors; LT falls 2%, Dr Reddy#39;s Labs hits 52-week high

The top gainers from Nifty index are YES Bank, Tata Motors, UPL, UltraTech Cement and Mahindra Mahindra while the top losers included Cipla, Larsen Toubro, ICICI Bank, Tata Steel and Bharti Infratel.
 Money Control1 month ago Stocks in the news: Yes Bank, Dr Reddy#39;s Lab, Ahluwalia Contracts, Bharti Airtel  Money Control2 months ago D-Street Buzz: Indiabulls Housing among most active on BSE; 78 stocks at 52-week low  Money Control2 months ago Stocks in the news: RIL, Infosys, ICICI Bank, Bharti Airtel and Dr Reddy's Labs  Economic Times2 months ago
Rediff.com

India-centric plans help Dr Reddy's outperform pharma market

In November, DRL registered growth of 28 per cent year-on-year (YoY), which was the highest among peers and double that of the industry growth (14.5 per cent). The focus of Dr Reddy’s Laboratories (DRL) on the domestic market seems to be paying off. This has helped the company outperform the domestic pharma market in seven of the last eight quarters. In November, DRL registered growth of 28 per cent year-on-year (YoY), which was the highest among peers and double that of the industry ...
 Rediff.com4 weeks ago

Dr Reddy’s share price climbs 1% after Credit Suisse maintains outperform rating

The near-term catalyst could be the increase in volume share in gSuboxone, Credit Suisse added.
 Money Control1 month ago
Economic Times

Dr Reddy's Q2 profit jumps twofold to Rs 1,093 crore on tax benefit

There was a tax benefit of Rs 330 crore due to recognition of deferred tax assets of Rs 520 crore. PTI | Nov 01, 2019, 01.28 PM IST New Delhi: Dr Reddy's Laboratories on Friday reported over two-fold jump in consolidated net profit to Rs 1,092.5 crore for the ...
 Economic Times2 months ago Dr Reddy's Q2 net jumps over two-fold to Rs 1,093 crore  Economic Times2 months ago Dr Reddy#39;s Q2 beats estimates, profit doubles to Rs 1,093 crore  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
Happening by Location Click on any location on map to view latest news by location
 
More     Less